Industry Research Reports and Market Analysis at MindBranch.com Research Index | Publishers | My Account | Contact Us | About MindBranch
Welcome Guest  (Login/Register) |  0 items
  
Advanced Search > | Tips >
Contact a
Research Assistant

US 800-774-4410
or +1-240-747-3094

Search Assistance >

Home  > Healthcare  >  Pharmaceutical  >  Drug Discovery

Regulatory Hurdles in European Drug Discovery


Published Date: January 2006
Published By: Frost & Sullivan
Page Count: 82
Order Code: R1-4610
 
DescriptionTable of ContentsSimilar
Products

1. Regulatory Hurdles in European Drug Discovery
        1. Overview
                1. Overview
        2. Research Scope & Methodology
                1. Research Scope & Methodology
        3. Key Definitions and Abbreviations
                1. Key Definitions and Abbreviations
        4. Introduction
                1. Introduction
        5. Overview of EC Directives
                1. Overview of EC Directives
        6. European Authorisation Procedure
                1. European Authorisation Procedure
        7. Regulatory Policy
                1. Regulatory Policy
        8. State Members of the European Union
                1. State Members of the European Union
        9. Applicants and Other European Countries
                1. Applicants and Other European Countries
        10. Regulatory Challenges
                1. Regulatory Challenges
        11. Regulatory Hurdles in Austrian Drug Discovery
                1. Regulatory Hurdles in Austrian Drug Discovery
        12. Regulatory Hurdles in Belgium Drug Discovery
                1. Regulatory Hurdles in Belgium Drug Discovery
        13. Regulatory Hurdles in Czech Republic Drug Discovery
                1. Regulatory Hurdles in Czech Republic Drug Discovery
        14. Regulatory Hurdles in Danish Drug Discovery
                1. Regulatory Hurdles in Danish Drug Discovery
        15. Regulatory Hurdles in Finnish Drug Discovery
                1. Regulatory Hurdles in Finnish Drug Discovery
        16. Regulatory Hurdles in French Drug Discovery
                1. Regulatory Hurdles in French Drug Discovery
        17. Regulatory Hurdles in German Drug Discovery
                1. Regulatory Hurdles in German Drug Discovery
        18. Regulatory Hurdles in Greek Drug Discovery
                1. Regulatory Hurdles in Greek Drug Discovery
        19. Regulatory Hurdles in Hungarian Drug Discovery
                1. Regulatory Hurdles in Hungarian Drug Discovery
        20. Regulatory Hurdles in Italian Drug Discovery
                1. Regulatory Hurdles in Italian Drug Discovery
        21. Regulatory Hurdles in Polish Drug Discovery
                1. Regulatory Hurdles in Polish Drug Discovery
        22. Regulatory Hurdles in Portuguese Drug Discovery
                1. Regulatory Hurdles in Portuguese Drug Discovery
        23. Regulatory Hurdles in Slovakian Drug Discovery
                1. Regulatory Hurdles in Slovakian Drug Discovery
        24. Regulatory Hurdles in Spanish Drug Discovery
                1. Regulatory Hurdles in Spanish Drug Discovery
        25. Regulatory Hurdles in Swedish Drug Discovery
                1. Regulatory Hurdles in Swedish Drug Discovery
        26. Regulatory Hurdles in the United Kingdom Drug Discovery
                1. Regulatory Hurdles in the United Kingdom Drug Discovery
        27. Conclusion
                1. The Future
        28. Decision Support Databases
                1. Decision Support Databases


Similar Products
Prostate Cancer Drug Discoveries: What the Future Holds
Published Nov 2009 by Espicom Healthcare Intelligence


Competitor Analysis: Thrombopoiesis-Stimulating Agents (TPO)
Published Nov 2009 by La Merie S.L.


Competitor Analysis: FSH, hCG and LH - Therapeutic Proteins for Assisted Reproductive Technology (ART)
Published Nov 2009 by La Merie S.L.


Competitor Analysis: FGF-R Agonists and Antagonists
Published Nov 2009 by La Merie S.L.


BI for Drug Development: Oracle Introduces Clinical Development Analytics
Published Nov 2009 by IDC


Canada's Pharmaceutical Industry - Porter’s Five Forces Strategy Analysis
Published Nov 2009 by Aruvian's R'search


Competitor Analysis: TGF-R Agonists and Antagonists
Published Nov 2009 by La Merie S.L.


Protein Kinase Therapeutics in Oncology - Where to Commercialize?
Published Oct 2009 by BioSeeker Group AB


CDK Inhibitors Patent Landscape 2009
Published Oct 2009 by France Innovation Scientifique et Transfer


Antidiabetics in Australia Market Forecast
Published Oct 2009 by Datamonitor




 


Privacy Policy | Terms & Conditions | Site Map | Return Policy | Help FAQs
Copyright © 1999-2008, All Rights Reserved, MindBranch.com
Trust-e Logo
Phone: 800-774-4410 (US) or +1-240-747-3094 (Int'l)
Hours: 7:00 a.m. to 7:00 p.m. EST Monday through Friday
Email: support@mindbranch.com